As previously discussed, the EXSCEL trial included a wide range of patients with T2DM, and the primary endpoint did not reach statistical significance (P = 0.06).
← all excerpts
GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data.
1
0.0600
0.0600